日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Potent, Selective, Small-Molecule Inhibitor of DHX9 Abrogates Proliferation of Microsatellite Instable Cancers with Deficient Mismatch Repair

DHX9 的强效、选择性小分子抑制剂可抑制错配修复缺陷的微卫星不稳定癌症的增殖

Jennifer Castro, Matthew H Daniels, David Brennan, Brian Johnston, Deepali Gotur, Young-Tae Lee, Kevin E Knockenhauer, Chuang Lu, Jie Wu, Sunaina Nayak, Cindy Collins, Rishabh Bansal, Shane M Buker, April Case, Julie Liu, Shihua Yao, Brian A Sparling, E Allen Sickmier, Serena J Silver, Stephen J Bla

Discovery of ATX968: An Orally Available Allosteric Inhibitor of DHX9

ATX968 的发现:一种口服有效的 DHX9 变构抑制剂

Daniels, Matthew H; Castro, Jennifer; Lee, Young-Tae; Gotur, Deepali; Knockenhauer, Kevin E; Grigoriu, Simina; Lockbaum, Gordon J; Cheong, Jae Eun; Lu, Chuang; Brennan, David; Buker, Shane M; Liu, Julie; Yao, Shihua; Sparling, Brian A; Sickmier, E Allen; Ribich, Scott; Blakemore, Steve J; Silver, Serena J; Boriack-Sjodin, P Ann; Duncan, Kenneth W; Copeland, Robert A

Characterization of exoribonuclease XRN1 as a cancer target and identification of adenosine-3',5'-bisphosphate as a potent enzyme inhibitor.

核糖核酸外切酶 XRN1 作为癌症靶点的特性分析以及腺苷-3',5'-二磷酸作为强效酶抑制剂的鉴定

Lockbaum Gordon J, Lynes Maureen M, Shen Sophie A, Liu Julie, Holt Nicholas, Nayak Sunaina P, Knockenhauer Kevin E, Yao Shihua, Sickmier E Allen, Raman Anugraha, Wu Jie, Case April, Shehaj Livia, Buker Shane M, Grigoriu Simina, Ribich Scott, Blakemore Stephen J, Sparling Brian A, Duncan Kenneth W, Copeland Robert A, Silver Serena J, Boriack-Sjodin P Ann

Crystal structures of the DExH-box RNA helicase DHX9

DExH盒RNA解旋酶DHX9的晶体结构

Lee, Young Tae; Sickmier, E Allen; Grigoriu, Simina; Castro, Jennifer; Boriack-Sjodin, P Ann

Crystal structures of human procathepsin H

人类蛋白酶原H的晶体结构

Yue Hao, Whitney Purtha, Christa Cortesio, Huan Rui, Yan Gu, Hao Chen, E Allen Sickmier, Paolo Manzanillo, Xin Huang

Development of 2-aminooxazoline 3-azaxanthene β-amyloid cleaving enzyme (BACE) inhibitors with improved selectivity against Cathepsin D

开发对组织蛋白酶D具有更高选择性的2-氨基噁唑啉-3-氮杂呫吨β-淀粉样蛋白裂解酶(BACE)抑制剂

Low, Jonathan D; Bartberger, Michael D; Chen, Kui; Cheng, Yuan; Fielden, Mark R; Gore, Vijay; Hickman, Dean; Liu, Qingyian; Allen Sickmier, E; Vargas, Hugo M; Werner, Jonathan; White, Ryan D; Whittington, Douglas A; Wood, Stephen; Minatti, Ana E

The Panitumumab EGFR Complex Reveals a Binding Mechanism That Overcomes Cetuximab Induced Resistance

帕尼单抗 EGFR 复合物揭示出一种克服西妥昔单抗诱导耐药性的结合机制

E Allen Sickmier, Robert J M Kurzeja, Klaus Michelsen, Mukta Vazir, Evelyn Yang, Andrew S Tasker

Rationale-Based Engineering of a Potent Long-Acting FGF21 Analog for the Treatment of Type 2 Diabetes

基于理论的强效长效 FGF21 类似物设计,用于治疗 2 型糖尿病

Randy Hecht, Yue-Sheng Li, Jeonghoon Sun, Ed Belouski, Michael Hall, Todd Hager, Junming Yie, Wei Wang, Dwight Winters, Stephen Smith, Chris Spahr, Lei-Ting Tam, Zhongnan Shen, Shanaka Stanislaus, Narumol Chinookoswong, Yvonne Lau, Allen Sickmier, Mark Leo Michaels, Thomas Boone, Murielle M Véniant,

Alternative conformations at the RNA-binding surface of the N-terminal U2AF(65) RNA recognition motif

N端U2AF(65) RNA识别基序的RNA结合表面的替代构象

Thickman, Karen R; Sickmier, E Allen; Kielkopf, Clara L

Structural basis for polypyrimidine tract recognition by the essential pre-mRNA splicing factor U2AF65

必需前 mRNA 剪接因子 U2AF65 识别多聚嘧啶束的结构基础

E Allen Sickmier, Katherine E Frato, Haihong Shen, Shanthi R Paranawithana, Michael R Green, Clara L Kielkopf